Related Experiment Videos
Parathyroid hormone secretion in chronic human endogenous hypercortisolism.
C M M Lanna1, F J A Paula, R M Montenegro
1Departamento de Clínica Médica, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brasil.
Summary
Patients with chronic hypercortisolism (CH) exhibit reduced bone mineral density (BMD) and an exaggerated parathyroid hormone (PTH) secretion in response to low calcium levels, suggesting a link to osteoporosis development.
Area of Science:
- Endocrinology
- Bone Metabolism
- Mineralocorticoid Disorders
Background:
- Osteoporosis is a frequent complication of Cushing's syndrome.
- The underlying mechanisms linking hypercortisolism to bone loss remain incompletely understood.
Purpose of the Study:
- To investigate parathyroid hormone (PTH) secretion patterns in patients with chronic hypercortisolism (CH).
- To evaluate bone mineral density (BMD) in individuals with CH.
Main Methods:
- Assessed PTH response to hypocalcemia (EDTA infusion) and hypercalcemia in 8 CH patients and 11 controls.
- Measured bone mineral density (BMD) using DEXA scans.
- Analyzed serum calcium, magnesium, and PTH levels during dynamic testing.
Main Results:
- CH patients demonstrated a significantly higher PTH secretory response to hypocalcemia compared to healthy controls.
- BMD was notably decreased in the spine of CH patients.
- No significant differences in PTH suppression during hypercalcemia were observed between groups.
Conclusions:
- Chronic hypercortisolism is associated with reduced bone mass, particularly in trabecular bone.
- Elevated PTH secretion in response to hypocalcemia in CH patients may contribute to the pathogenesis of osteoporosis.